Sat, Nov 22, 2014, 10:51 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • ellid@ymail.com ellid Aug 18, 2014 11:38 AM Flag

    Why Synta Pharmaceuticals Corp. Shares Skyrocketed By Brian Pacampara July 29, 2013

    Why Synta Pharmaceuticals Corp. Shares Skyrocketed
    By Brian Pacampara | More Articles | Save For Later
    July 29, 2013 | Comments (1)

    Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

    What: Shares of biotechnology company Synta Pharmaceuticals Corp. (NASDAQ: SNTA ) soared a whopping 43% today, after results from a mid-stage study of its drug ganetespib in breast cancer patients warranted an expansion of the study.

    So what: Synta said that ganetespib helped enough patients with triple-negative breast cancer to support a second stage of the trial, reinforcing optimism over the drug's blockbuster potential of treating different types of cancers. In fact, according to the American Cancer Society, triple-negative breast cancer is particularly fast-spreading and difficult to treat, so the surprising results should help Synta garner some big-pharma partnership support as well.

 
SNTA
3.18+0.09(+2.91%)Nov 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Hexcel Corp.
NYSEFri, Nov 21, 2014 4:02 PM EST